APP
PLXP

Avantax Planning Partners’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Avantax Planning Partners’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,000
Closed -$7K – 382
2022
Q3 		$7K Buy
+10,000
New +$14.7K ﹤0.01% 344

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Avantax Planning Partners's PLXP Position: Q4 2022 in Review

Avantax Planning Partners sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 10,000 shares — an estimated $7K sold.

Avantax Planning Partners first reported a position in PLXP in Q3 2022 and held it in 1 quarter. The position peaked at $7K in Q3 2022. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • Avantax Planning Partners reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Avantax Planning Partners sold 10,000 PLx Pharma Inc. Common Stock shares in Q4 2022, an estimated $7K.
  • Avantax Planning Partners first reported a position in PLx Pharma Inc. Common Stock in Q3 2022 and held it in 1 quarter.
  • Avantax Planning Partners's PLx Pharma Inc. Common Stock position peaked at $7K in Q3 2022.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on Avantax Planning Partners's 13F filing for Q4 2022, filed 10 Feb 2023.